Allscripts Healthcare Solutions Receives New Coverage from Analysts at Citigroup Inc. (MDRX)
Research analysts at Citigroup Inc. initiated coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a report released on Tuesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating on the stock.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 16.69 on Tuesday. Allscripts Healthcare Solutions has a 1-year low of $11.04 and a 1-year high of $17.58. The stock has a 50-day moving average of $16.09 and a 200-day moving average of $15.18. The company’s market cap is $2.974 billion.
A number of other firms have also recently commented on MDRX. Analysts at RBC Capital initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Thursday, February 13th. They set an “outperform” rating and a $20.00 price target on the stock. Separately, analysts at Maxim Group upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Tuesday, February 11th. They now have a $20.00 price target on the stock. Finally, analysts at Thomson Reuters/Verus upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Monday, February 3rd. Nine research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Allscripts Healthcare Solutions currently has a consensus rating of “Hold” and a consensus price target of $17.47.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.